The adenophostins exhibit approximately 10-100 times higher receptor bindin
g and Ca2+ mobilising potencies in comparison with the natural second messe
nger D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P-3]. Despite many synth
etic attempts to determine the minimal structural requirement for this unus
ual behaviour of the adenophostins, few related simplified analogues displa
ying higher activity than that of Ins(1.4,5)P-3 have been reported. However
, biological evaluation of such analogues has revealed that one of the key
factors for the enhanced biological activity is the adenine moiety. To furt
her understand the effect that the adenine base has upon the activity of th
e adenophostins, congeners in which this functionality is replaced by uraci
l, benzimidazole, 2-methoxynaphthalene, 4-methylanisole and 4-methylnaphtha
lene using the common intermediate 1,2-di-O-acetyl-5-O-benzyl-3-O-(3,4-di-O
-acetyl-2,6-di-O-benzyl-alpha -D-glucopyranosyl)-ribofuranose have been syn
thesised using a base replacement strategy. The synthesis of the uracil and
benzimidazole analogues was achieved using the Vorbruggen condensation pro
cedure. The 1'-C-glycosidic analogues were prepared using Friedel-Crafts ty
pe C-aryl glycosidation reactions. Phosphate groups were introduced using t
he phosphoramidite method with subsequent removal of all-benzyl protecting
groups by catalytic hydrogenation or catalytic hydrogen transfer. Apart fro
m one analogue with an alpha -glycosidic linkage all compounds were more po
tent than Ins(1,4,5)P-3 and most tended more towards adenophostin in activi
ty. These analogues will be valuable tools to unravel the role that the ade
nine moiety plays in the potent activity of the adenophostins and demonstra
te that this strategy is effective at producing highly potent ligands.